2,4,6-TMPEA-NBOMe, also known as ψ-2C-O-NBOMe or 26O-NBOMe as well as N-(2-methoxybenzyl)-2,4,6-trimethoxyphenethylamine, is a psychedelic drug of the phenethylamine, ψ-PEA, and N-benzylphenethylamine (NBOMe) families. It is the NBOMe derivative of ψ-2C-O (2,4,6-TMPEA). The drug is said to produce psychedelic effects such as visuals. It has been found to act as a potent serotonin 5-HT2A receptor partial agonist, with an of 1.7nM and an of 49%. 2,4,6-TMPEA-NBOMe was first described in the scientific literature in 2009. Subsequently, it was encountered as a novel designer drug in Russia in 2015. The drug is a controlled substance in Canada under phenethylamine blanket-ban language.
See also 25-NB (psychedelics) NBOMe-mescaline (3,4,5-TMPEA-NBOMe) 25O-NBOMe (2,4,5-TMPEA-NBOMe)
References
External links 26O-NBOMe - Isomer Design